All In Biotech

Drug Trial Radar · NCT03052608

A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC

A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY OF LORLATINIB (PF-06463922) MONOTHERAPY VERSUS CRIZOTINIB MONOTHERAPY IN THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER

Last checked: Nov 20, 2026Latest source record: Nov 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingPhase 3. Randomized with 296 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

296

Actual

Start

Apr 27, 2017

Primary completion

Mar 20, 2020

Study completion Dec 31, 2028

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Feb 14, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A phase 3 study to demonstrate whether lorlatinib given as monotherapy is superior to crizotinib alone in prolonging the progression-free survival in advanced ALK-positive NSCLC patients who are treatment naïve and to compare lorlatinib to crizotinib with respect to overall survival in the same population

Conditions

  • Carcinoma, Non-Small-Cell Lung

Interventions

  • LorlatinibDrug

    ALK-positive NSCL treatment

  • CrizotinibDrug

    ALK-positive NSCL treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-Free Survival (PFS) Based on Blinded Independent Central Review (BICR) AssessmentTime frame: From time of Study Start up to 33 months

Locations

166 sites in 23 countries. Site status is shown where the registry gives one.

  • Florida Cancer Specialists

    Altamonte Springs, Florida

  • Florida Cancer Specialists

    Brandon, Florida

  • Florida Cancer Specialists

    Clearwater, Florida

  • Florida Cancer Specialists

    Gainesville, Florida

  • Florida Cancer Specialists

    Largo, Florida

  • Florida Cancer Specialists

    Lecanto, Florida

  • Florida Cancer Specialists

    Orange City, Florida

  • Florida Cancer Specialists

    Orlando, Florida

  • Florida Cancer Specialists

    Spring Hill, Florida

  • Florida Cancer Specialists

    St. Petersburg, Florida

  • Florida Cancer Specialists

    Tampa, Florida

  • Florida Cancer Specialists

    Tavares, Florida

  • Florida Cancer Specialists

    The Villages, Florida

  • Florida Cancer Specialists

    Winter Park, Florida

  • Massachusetts Eye and Ear Infirmary

    Boston, Massachusetts

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Ophthalmic Consultants of Boston Inc

    Boston, Massachusetts

  • The William P. Beetham Eye Institute, Joslin Diabetes Center

    Boston, Massachusetts

  • University of Rochester Cancer Center Pharmacy

    Rochester, New York

  • University of Rochester Medical Center

    Rochester, New York

  • Tennessee Oncology, PLLC

    Dickson, Tennessee

  • Tennessee Oncology, PLLC

    Franklin, Tennessee

  • Tennessee Oncology, PLLC

    Gallatin, Tennessee

  • Tennessee Oncology, PLLC

    Hermitage, Tennessee

  • Tennessee Oncology, PLLC

    Lebanon, Tennessee

  • Tennessee Oncology, PLLC

    Murfreesboro, Tennessee

  • Tennessee Oncology, PLLC

    Nashville, Tennessee

  • The Sarah Cannon Research Institute.

    Nashville, Tennessee

  • Tennessee Oncology, PLLC

    Nashville, Tennessee

  • Tennessee Oncology, PLLC

    Nashville, Tennessee

  • Tennessee Oncology, PLLC

    Nashville, Tennessee

  • Tennessee Oncology, PLLC

    Shelbyville, Tennessee

  • Tennessee Oncology, PLLC

    Smyrna, Tennessee

  • University of Washington Medical Center

    Seattle, Washington

  • Centro Medico Austral

    CABA, Argentina

  • Centro de Investigacion Pergamino SA

    Pergamino, Buenos Aires, Argentina

  • Bendigo Day Surgery Collection Centre and Laboratory

    Bendigo, Victoria, Australia

  • Bendigo Medical Imaging, Bendigo Hospital

    Bendigo, Victoria, Australia

  • Melbourne Pathology

    Bendigo, Victoria, Australia

  • Peter MacCallum Cancer Centre

    Melbourne, Victoria, Australia

Showing 40 of 166 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.